BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6375615)

  • 1. Calcium blockers in smooth-muscle disorders. Current status.
    Schwartz ML; Rotmensch HH; Vlasses PH; Ferguson RK
    Arch Intern Med; 1984 Jul; 144(7):1425-9. PubMed ID: 6375615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some extracardiac effects of diltiazem and other calcium entry blockers.
    Andersson KE
    Acta Pharmacol Toxicol (Copenh); 1985; 57 Suppl 2():31-43. PubMed ID: 3904331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of calcium inhibitors excluding cardiac pathology and arterial hypertension].
    Hugues FC; Le Jeunne C
    Therapie; 1989; 44(3):175-81. PubMed ID: 2675379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydropyridines and vascular diseases.
    Tamargo J; Delpón E
    Z Kardiol; 1991; 80 Suppl 7():106-11. PubMed ID: 1792815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinical pharmacology of calcium channel blockers.
    Kim KE
    Am Fam Physician; 1991 Feb; 43(2):583-8. PubMed ID: 1990741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Employment of calcium antagonists in extracardial diseases].
    Husted SE; Nielsen HK; Krusell LR
    Ugeskr Laeger; 1986 Mar; 148(12):705-8. PubMed ID: 3961966
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of calcium on excitation-contraction coupling in cardiac and vascular smooth muscle.
    Lucchesi BR
    Circulation; 1989 Dec; 80(6 Suppl):IV1-13. PubMed ID: 2557175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising uses of calcium-channel blocking agents.
    Bussey HI; Talbert RL
    Pharmacotherapy; 1984; 4(3):137-43. PubMed ID: 6377247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
    Altura BM; Altura BT
    Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blockers and motility disorders of the esophagus.
    Andersson KE
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():201-4. PubMed ID: 3716828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advance in calcium channel blockers relaxing corpus cavernosum smooth muscle].
    Xiao HJ; Liu JH
    Zhonghua Nan Ke Xue; 2003 Feb; 9(1):55-7. PubMed ID: 12680335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of action of calcium antagonists in the treatment of vascular diseases].
    Mayerhofer S
    Wien Med Wochenschr; 1986 Nov; 136(21-22):591-4. PubMed ID: 2435066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between predicted theoretical mechanistic biochemistry (TMB) data and therapeutic effects in the management of vascular disorders with calcium channel blockers.
    Akintonwa DA; Odigwe CO
    Med Hypotheses; 2000 Jun; 54(6):944-7. PubMed ID: 10867744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fundamentals of calcium channel blockers.
    Das G
    Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):575-84. PubMed ID: 3061939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel antagonists. What do the second-generation agents have to offer?
    Salerno SM; Zugibe FT
    Postgrad Med; 1994 Jan; 95(1):181-90. PubMed ID: 8278298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonists: accounts on new perspectives of their use and an update on side effects].
    Palombo C; Mian M; Bertelli A
    Clin Ter; 1989 Feb; 128(3):149-64. PubMed ID: 2524306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New uses for calcium channel blockers. Therapeutic implications.
    Fisher M; Grotta J
    Drugs; 1993 Dec; 46(6):961-75. PubMed ID: 7510613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of nifedipine and other calcium antagonists in patients with primary esophageal motor dysfunctions.
    Baunack AR; Weihrauch TR
    Arzneimittelforschung; 1991 Jun; 41(6):595-602. PubMed ID: 1930346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of calcium antagonists in the treatment of arterial hypertension].
    Velasco M; Negrín C
    Invest Clin; 1997 Nov; 38 Suppl 2():65-72. PubMed ID: 9471233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis.
    Thompson AE; Shea B; Welch V; Fenlon D; Pope JE
    Arthritis Rheum; 2001 Aug; 44(8):1841-7. PubMed ID: 11508437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.